Abbott Laboratories continues to pursue enforcement of its patent rights relating to fenofibrate tablets (a drug Abbott sells under the trademark Tricor(R)).
In a case filed in the U.S. District Court…
Abbott Laboratories denies all substantive allegations in each of Medinol Limited’s patent infringement suits in Ireland, the Netherlands, and Germany.
In December 2008, Medinol sued Abbott in three European countries claiming…
Abbott Laboratories continues to face several lawsuits by Evysio Medical Devices ULC over the alleged infringement of certain stent design patents pending in various jurisdictions.
A case is pending against Abbott…
Abbott Laboratories continues to deny the allegations in the patent infringement lawsuit filed by Johnson & Johnson, Inc. and Cordis Corporation, a wholly owned subsidiary of Johnson & Johnson (collectively…
A case is pending against Abbott Laboratories in the Eastern District of Texas, in which New York University (NYU) and Centocor, Inc. assert that Humira(R) infringes a patent co-owned by…
The damages phase of Abbott Laboratories’ patent suit against Arterial Vascular Engineering, Inc. (now known as Medtronic Vascular, Inc.) awaits the outcome of Medtronic’s appeal to the infringement and validity…
Abbott Laboratories is facing patent infringement lawsuits separately filed by certain Medtronic, Inc. companies and Wall Cardiovascular Technologies, LLC in the U.S. District Court for the Eastern District of Texas.
A…
Genzyme Corp. is in a dispute with Abbott Laboratories over the percentage of infringing product that was supplied by the Company.
The Company said that it may in the future…
Cordis Corp., a Johnson & Johnson subsidiary, pursues several patent infringement lawsuits in New Jersey Federal District Court against Guidant Corporation, Abbott Laboratories, Inc., Boston Scientific Corporation and Medtronic AVE,…
Baxter International Inc.’s appeal on the injunction against its generic sevoflurane product in Colombia in a dispute with Abbott Laboratories was granted, according to the Company’s Form 10-Q dated July…